[ET Net News Agency, 23 October 2020] Sino Biopharmaceutical Limited (01177) said the
anti-infective drug "Cefuroxime Axetil Tablet" of the group has obtained the notice of
approval of supplemental applications issued by the National Medical Products
Administration of the People's Republic of China and has passed the Consistency of Quality
and Efficacy Evaluation for Generic Drugs.
Cefuroxime axetil tablet, a second generation cephalosporin-type drug, is widely adopted
for clinical applications and is suitable for the treatment of infections caused by
susceptible strains of pathogens. (RC)